News

KKR has acquired a majority stake in HealthCare Royalty Partners, pushing the investment firm further into the healthcare ...
As part of the transaction, HCRx Chairman and CEO Clarke Futch will continue to lead the HCRx team and will maintain an ongoing substantial minority interest in HCRx.
Investment firm KKR (NYSE:KKR) announced on Wednesday the acquisition of a majority stake in biopharma royalty acquisition company, HealthCare Royalty Partners. The acquisition marks KKR's expansion ...
KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company ...
Contacts HealthCare Royalty Partners Carlos Almodovar, 203-487-8311 [email protected] ...
KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...
HealthCare Royalty Partners (HCRP) is a global healthcare investment firm focused on investing primarily in commercial stage healthcare product assets. HCRP manages over $3 billion and is ...
HealthCare Royalty Partners has closed its latest health-care private equity fund, HealthCare Royalty Partners IV, with a total of $1.8 billion for the fund and affiliated entities, a news release ...
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from Ardelyx Japanese collaboration ...
Clarke Futch, co-founder and managing partner of health care investment firm HealthCare Royalty Partners, poses for a photo inside his office at 300 Atlantic St., in downtown Stamford, Conn., on ...